Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04954469
What this trial is testing

B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency

Who this might be right for
Immune Deficiency Disease
University Hospital Tuebingen 54
Not applicableStudy completedNCT04871841
What this trial is testing

Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

Who this might be right for
Covid19Vaccine Adverse Reaction
Karaganda Medical University 82
Testing effectiveness (Phase 2)Study completedNCT00808262
What this trial is testing

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
Neovacs 21
Early research (Phase 1)Study completedNCT00000746
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00778388
What this trial is testing

Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers

Who this might be right for
Healthy
Valneva Austria GmbH 157
Testing effectiveness (Phase 2)WithdrawnNCT05663086
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd.
Early research (Phase 1)Study completedNCT05131373
What this trial is testing

Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris

Who this might be right for
Acne VulgarisAcne
Sanofi Pasteur, a Sanofi Company 38
Large-scale testing (Phase 3)Study completedNCT00511914
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008

Who this might be right for
Seasonal Influenza Vaccine
Novartis Vaccines 135
Testing effectiveness (Phase 2)Study completedNCT01040715
What this trial is testing

Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists

Who this might be right for
Rheumatoid Arthritis
Neovacs 40
Large-scale testing (Phase 3)Active Not RecruitingNCT07047521
What this trial is testing

A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

Who this might be right for
Dengue Fever
Takeda 496
Early research (Phase 1)Study completedNCT02501421
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine

Who this might be right for
Tuberculosis
Research Institute for Biological Safety Problems 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833943
What this trial is testing

Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia.

Who this might be right for
Oligozoospermia and/or Asthenozoospermia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 72
Testing effectiveness (Phase 2)Ended earlyNCT04498247
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 263
Early research (Phase 1)Study completedNCT00189943
What this trial is testing

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Who this might be right for
Smallpox
Bavarian Nordic 90
Large-scale testing (Phase 3)Study completedNCT02581410
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

Who this might be right for
Herpes Zoster
GlaxoSmithKline 430
Large-scale testing (Phase 3)Study completedNCT04143061
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,328
Large-scale testing (Phase 3)Study completedNCT05386810
What this trial is testing

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 1,572
Testing effectiveness (Phase 2)Study completedNCT00989196
What this trial is testing

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Octapharma 22
Not applicableUnknownNCT05191368
What this trial is testing

Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases

Who this might be right for
Rheumatic Disease
Yunnan University of Chinese Medicine 500
Large-scale testing (Phase 3)Study completedNCT00161811
What this trial is testing

Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation